Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - solifenacin succinate - film coated tablet - 10 milligram - solifenacin

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - solifenacin succinate 10mg;   - film coated tablet - 10 mg - active: solifenacin succinate 10mg   excipient: hypromellose   iron oxide red lactose monohydrate macrogol 6000 magnesium stearate pregelatinised maize starch purified talc titanium dioxide - solifenacin sandoz is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent miturition, and/or urge incontinence.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - solifenacin succinate 5mg;   - film coated tablet - 5 mg - active: solifenacin succinate 5mg   excipient: hypromellose   iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate pregelatinised maize starch purified talc titanium dioxide - solifenacin sandoz is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent miturition, and/or urge incontinence.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - solifenacin succinate, quantity: 10 mg - tablet - excipient ingredients: maize starch; hypromellose; purified talc; magnesium stearate; lactose monohydrate; titanium dioxide; propylene glycol; iron oxide yellow; iron oxide red - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - solifenacin succinate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified talc; hypromellose; magnesium stearate; titanium dioxide; propylene glycol; iron oxide yellow - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.8 mg) - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; pregelatinised maize starch; lactose monohydrate; purified talc; macrogol 6000 - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: iron oxide red; purified talc; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; magnesium stearate; macrogol 6000 - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.8 mg) - tablet, film coated - excipient ingredients: iron oxide yellow; macrogol 6000; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; pregelatinised maize starch; purified talc - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: purified talc; macrogol 6000; lactose monohydrate; hypromellose; magnesium stearate; pregelatinised maize starch; iron oxide red; titanium dioxide - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Canada - English - Health Canada

jamp pharma corporation - solifenacin succinate - tablet - 5mg - solifenacin succinate 5mg - antimuscarinics